Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

NGR-human tumour necrosis factor

EU orphan designation number: EU/3/08/549   
Active ingredient: NGR-human tumour necrosis factor
Indication: Treatment of malignant mesothelioma
Sponsor: MolMed S.p.A.
Via Olgettina 58, 20132 Milano, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
5/06/2008 Orphan designation EMEA/OD/003/08 (2008)2532 of 3/06/2008